OtherDrug Discovery and Translational Medicine
Fate determination role of erythropoietin and romiplostim in the lineage commitment of hematopoietic progenitors
Xiaoqing Fan, Wojciech Krzyzanski, Raymond S. M. Wong and Xiaoyu Yan
Journal of Pharmacology and Experimental Therapeutics April 30, 2022, JPET-AR-2022-001130; DOI: https://doi.org/10.1124/jpet.122.001130
Xiaoqing Fan
1School of Pharmacy, The Chinese University of Hong Kong, Hong Kong
Wojciech Krzyzanski
2Pharmaceutical Sciences, University at Buffalo, United States
Raymond S. M. Wong
3Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong
Xiaoyu Yan
1School of Pharmacy, The Chinese University of Hong Kong, Hong Kong
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherDrug Discovery and Translational Medicine
Fate determination role of erythropoietin and romiplostim
Xiaoqing Fan, Wojciech Krzyzanski, Raymond S. M. Wong and Xiaoyu Yan
Journal of Pharmacology and Experimental Therapeutics April 30, 2022, JPET-AR-2022-001130; DOI: https://doi.org/10.1124/jpet.122.001130
OtherDrug Discovery and Translational Medicine
Fate determination role of erythropoietin and romiplostim
Xiaoqing Fan, Wojciech Krzyzanski, Raymond S. M. Wong and Xiaoyu Yan
Journal of Pharmacology and Experimental Therapeutics April 30, 2022, JPET-AR-2022-001130; DOI: https://doi.org/10.1124/jpet.122.001130
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement